Evidence map›Paper›PMID 41339979›Full record

ArticleInternational microbiology : the official journal of the Spanish Society for Microbiology2025

Plasmid-mediated carbapenem resistance: global dissemination patterns and replicon-gene associations.

Hannay Crystynah Almeida de Souza, Arlen Carvalho de Oliveira Almeida, Anamaria Mota Pereira Dos Santos, Ana Beatriz Portes, Juliana Fidelis, Pedro Panzenhagen, Carlos Adam Conte Junior

Abstract read
PubMed Publisher
In one paragraph

Article in International microbiology : the official journal of the Spanish Society for Microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hannay Crystynah Almeida de SouzaCenter for Food Analysis (NAL), Technological Development Support Laboratory (LADETEC), Federal University of Rio de Janeiro (UFRJ), Cidade Universitária, Rio de Janeiro, 21941-598, Brazil.
Arlen Carvalho de Oliveira AlmeidaCenter for Food Analysis (NAL), Technological Development Support Laboratory (LADETEC), Federal University of Rio de Janeiro (UFRJ), Cidade Universitária, Rio de Janeiro, 21941-598, Brazil.
Anamaria Mota Pereira Dos SantosCenter for Food Analysis (NAL), Technological Development Support Laboratory (LADETEC), Federal University of Rio de Janeiro (UFRJ), Cidade Universitária, Rio de Janeiro, 21941-598, Brazil.
Ana Beatriz PortesCenter for Food Analysis (NAL), Technological Development Support Laboratory (LADETEC), Federal University of Rio de Janeiro (UFRJ), Cidade Universitária, Rio de Janeiro, 21941-598, Brazil.
Juliana FidelisCenter for Food Analysis (NAL), Technological Development Support Laboratory (LADETEC), Federal University of Rio de Janeiro (UFRJ), Cidade Universitária, Rio de Janeiro, 21941-598, Brazil.
Pedro PanzenhagenGraduate Program in Biochemistry (PPGBq), Institute of Chemistry (IQ), Federal University of Rio de Janeiro (UFRJ), Cidade Universitária, Rio de Janeiro, RJ, 21941-909, Brazil. pedropanzen@iq.ufrj.br.
Carlos Adam Conte JuniorCenter for Food Analysis (NAL), Technological Development Support Laboratory (LADETEC), Federal University of Rio de Janeiro (UFRJ), Cidade Universitária, Rio de Janeiro, 21941-598, Brazil.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 313119/2020-1Coordenação de Aperfeiçoamento de Pessoal de Nível Superior FinanceCode001Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/2002.514/2024Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E26/204.078/2022Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro E26/202.227/2018
6 · The paper itself

Abstract

Carbapenem resistance, especially among members of the Enterobacterales order, poses a serious challenge to public health today. This scenario is further intensified by the dissemination of plasmids carrying carbapenemase-encoding genes, which complicates the control of multidrug-resistant organisms. In this study, we analyzed plasmid sequences and metadata available in the PLSDB database to investigate the global dissemination of carbapenem resistance genes, examining the taxonomy of the isolates, the source of isolation, and the geographic location. We aimed to identify statistically significant associations between plasmid replicons and carbapenemase genes to better elucidate the patterns of gene dissemination. Significant correlations were observed between the IncL, ColKP3, IncM2, IncC, IncFII(pHN7A8), IncR and IncFII replicons and the blaOXA−48, blaOXA−181, blaIMP−1, blaNDM−4, ​​blaKPC−2, blaKPC−2 and blaNDM−5 genes, respectively. Interestingly, we identified a negative association between the blaKPC−2 gene and the IncL and IncX3 replicons, suggesting a possible exclusion or incompatibility mechanism that remains to be elucidated. These findings underscore the complexity of replicon-gene interactions, whose understanding is crucial for the development of more precise and effective interventions, while also highlighting the role of plasmid replicons in shaping the global epidemiology of carbapenem resistance. Additional experimental studies are needed to accurately validate these associations and unravel the molecular mechanisms underlying these findings.

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-Lactamasesbeta-Lactam ResistanceCarbapenem-Resistant EnterobacteriaceaeCarbapenemsPlasmidsRepliconEnterobacteriaceae InfectionsGene Transfer, HorizontalHumansAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsAMRCarbapenem resistanceCRKpReplicon-geneResistant plasmid

Identifiers

PMID41339979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.